algorithms.eod_public.1.1.tables.ss2018_pleura_60930.json Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of staging-client-java Show documentation
Show all versions of staging-client-java Show documentation
A cancer staging client library
{
"id" : "ss2018_pleura_60930",
"algorithm" : "eod_public",
"version" : "1.1",
"name" : "SS2018: Pleural Mesothelioma",
"title" : "Summary Stage 2018: Pleural Mesothelioma",
"subtitle" : "Summary Stage 2018",
"notes" : "**Pleural Mesothelioma**\n\n9050-9053 \n\nC340-C343, C348-C349, C384\nC340 Main bronchus\nC341 Upper lobe, lung\nC342 Middle lobe, lung\nC343 Lower lobe, lung\nC348 Overlapping lesion of lung\nC349 Lung, NOS\nC384 Pleura\n\n**Note 1:** The following sources were used in the development of this chapter\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 37 *Malignant Pleural Mesothelioma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** Code 0 is not applicable for this chapter.\n\n**Note 3:** Most pleural effusions are due to tumor. When the cytopathological examinations of pleural fluid are negative for tumor, the effusion should be excluded as a staging element and the tumor should not be classified as metastasis.\n* The physician statement of pleural effusion can be used to code this data item\n* If the physician feels the pleural effusion is due to tumor, despite negative cytology, the physician’s assessment can be used.\n* If pleural fluid cytology is described as suspicious/suspicious for mesothelioma, code 7",
"footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) Rusch, V.W., et al. **Malignant Plural Mesothelioma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 457-468",
"last_modified" : "2018-04-19T21:51:25.789Z",
"definition" : [ {
"key" : "ss2018",
"name" : "SS2018",
"type" : "INPUT"
}, {
"key" : "description",
"name" : "Description",
"type" : "DESCRIPTION"
} ],
"rows" : [ [ "1", "Localized only (localized, NOS)\n- Confined to pleura, NOS\n- Invasive tumor (mesothelioma) confined to pleura, NOS \n- Ipsilateral parietal pleura WITH or WITHOUT involvement of\n + Diaphragmatic pleural\n + Mediastinal pleura \n + Parietal pleura\n + Visceral pleura" ], [ "2", "Regional by direct extension only\n- Adjacent (connective) tissue, NOS\n- Chest wall \n- Confluent visceral pleural tumor (including any involvement of interlobar fissure)\n- Diaphragmatic muscle\n- Endothoracic fascia\n- Ipsilateral pleural surfaces all involved \n + Diaphragmatic, parietal, mediastinal, and visceral\n- Lung parenchyma, or lung involvement, NOS\n- Mediastinal fat (mediastinal tissues)\n- Mediastinal organs (direct extension)\n- Nodule(s) beneath visceral pleural surface (ipsilateral pleura)\n- Pericardium (extension through the internal surface) (non-transmural, NOS) WITHOUT pericardial effusion\n- Pulmonary parenchyma (visceral pleural extension)\n- Rib" ], [ "3", "Regional lymph node(s) involved only\n- Aortic (above diaphragm), NOS\n + Ascending aorta (phrenic)\n + Peri/para-aortic\n + Subaortic (aortico-pulmonary window)\n- Carinal (tracheobronchial) (tracheal bifurcation)\n- Hilar (ipsilateral)\n + Bronchopulmonary\n + Proximal lobar\n + Pulmonary root\n- Intercostal\n- Internal mammary (parasternal)\n- Intrapulmonary\n + Interlobar\n + Lobar\n + Segmental\n + Subsegmental\n- Mediastinal, NOS (ipsilateral)\n + Anterior\n + Posterior (tracheoesophageal)\n- Pericardial\n- Peri/parabronchial\n- Peri/paraesophageal (below carina)\n- Peri/paratracheal (lower [azygos], upper, NOS)\n- Pretracheal and retrotracheal (precarinal), NOS\n- Prevascular\n- Pulmonary ligament\n- Subcardial\n- Subcarinal\n- Regional lymph node(s), NOS\n + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s)/lymph node(s) involved\n- Distant site(s) (including further contiguous extension)\n + Brachial plexus\n + Cervical (neck) tissues\n + Contralateral lung\n + Contralateral pleura (direct contiguous extension)\n + Contralateral pleura/chest wall (discontinuous involvement)\n + Heart muscle\n + Intra-abdominal organs\n + Mediastinal organs (discontinuous involvement)\n + Mesothelioma WITH malignant pleural fluid\n + Pericardial effusion, malignant\n + Pericardium WITH pericardial effusion\n + Peritoneum (direct transdiaphragmatic extension of tumor)\n + Peritoneum (discontinuous extension of tumor)\n + Pleural effusion (see Note 3)\n + Spine\n- Distant lymph node(s), NOS\n + Hilar (contralateral, bilateral)\n * Bronchopulmonary\n * Proximal lobar\n * Pulmonary root\n + Mediastinal (contralateral, bilateral)\n * Anterior\n * Posterior (tracheoesophageal)\n + Peridiaphragmatic (ipsilateral, contralateral)\n * Mediastinal\n + Scalene (ipsilateral, contralateral) \n * Inferior deep cervical\n + Supraclavicular (ipsilateral or contralateral)\n * Transverse cervical\n- Distant metastasis, NOS\n + Carcinomatosis\n + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}